Categories Health Care, LATEST

Intuitive Surgical’s Q3 results surpass expectations

Intuitive Surgical (NASDAQ: ISRG) beat revenue and earnings expectations for the third quarter of 2019, sending the shares climbing 4.4% in aftermarket hours on Thursday.

Total revenue grew 23% year-over-year to $1.12 billion, beating estimates of $1.06 billion. The growth in revenue was driven by increased procedures and systems placements.  

Intuitive Surgical reports Q3 2019 earnings results

GAAP net income was $397 million, or $3.33 per share, compared to $293 million, or $2.45 per share, in the prior-year quarter. Adjusted net income totaled $409 million, or $3.43 per share, topping forecasts of $2.99 per share.

During the quarter, worldwide da Vinci procedures grew nearly 20% versus last year, driven mainly by growth in US general surgery procedures and worldwide urologic procedures. Intuitive shipped 275 da Vinci Surgical Systems, which was up 19% from the prior-year period, and grew its da Vinci Surgical System installed base to 5,406 systems as of quarter-end, reflecting a year-over-year increase of 12%.

Also read: Intuitive Surgical Q3 2019 Earnings Preview

Instrument and accessory revenue increased 25% year-over-year to $606 million, mainly driven by a growth in da Vinci procedure volume. Systems revenue rose by 23% to $339 million.

Intuitive ended the third quarter with $5.4 billion in cash, cash equivalents, and investments.

In August, the company acquired Scholly Fiberoptic’s robotic endoscope business, which is expected to strengthen the supply chain and increase manufacturing capacity for imaging products.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

SBUX Earnings: Key quarterly highlights from Starbucks’ Q4 2024 financial results

Starbucks Corporation (NASDAQ: SBUX) reported its fourth quarter 2024 earnings results today. Consolidated net revenues declined 3%, including on a constant currency basis, to $9.1 billion compared to the same

Key highlights from Biogen’s (BIIB) Q3 2024 earnings results

Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today. Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on a constant currency basis as

Infographic: Caterpillar (CAT) reports lower Q3 revenue and adj. profit

Caterpillar Inc. (NYSE: CAT), a leading manufacturer of construction and mining equipment, on Wednesday reported a decrease in revenue and adjusted earnings for the third quarter of 2024. Sales and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top